AA
EBS icon

Ancora Advisors’s Emergent Biosolutions EBS Stock Holding History

Ancora Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.95M Buy
1,067,867
+658,600
+161% +$5.51M 0.17% 138
2026
Q1 		$3.4M Buy
409,267
+238,798
+140% +$2.47M 0.07% 215
2025
Q4 		$2.11M Buy
+170,469
New +$1.83M 0.04% 295
2021
Q4 		– Sell
-80
Closed -$4K – 2392
2021
Q3 		$4K Sell
80
-90
-53% -$5.45K ﹤0.01% 1952
2021
Q2 		$11K Sell
170
-540
-76% -$34.7K ﹤0.01% 1504
2021
Q1 		$66K Sell
710
-27,309
-97% -$2.8M ﹤0.01% 979
2020
Q4 		$2.51M Buy
28,019
+10,210
+57% +$937K 0.08% 231
2020
Q3 		$1.84M Sell
17,809
-14,199
-44% -$1.53M 0.07% 233
2020
Q2 		$2.53M Buy
32,008
+11,590
+57% +$864K 0.11% 195
2020
Q1 		$1.18M Buy
20,418
+6,788
+50% +$391K 0.05% 297
2019
Q4 		$735K Buy
13,630
+330
+2% +$17.9K 0.03% 438
2019
Q3 		$695K Buy
+13,300
New +$620K 0.03% 398

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Ancora Advisors's EBS Position: Q2 2026 in Review

Ancora Advisors increased its Emergent Biosolutions (EBS) stake by 161% in Q2 2026, buying an estimated $5.51M and bringing the position to 1,067,867 shares worth $8.95M. The position accounts for 0.17% of the portfolio, ranked #138.

Ancora Advisors first reported a position in EBS in Q3 2019 and has held it in 12 quarters since. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Ancora Advisors held 1,067,867 shares of Emergent Biosolutions worth $8.95M as of Q2 2026.
  • Ancora Advisors bought 658,600 Emergent Biosolutions shares in Q2 2026, an estimated $5.51M.
  • Emergent Biosolutions made up 0.17% of Ancora Advisors's portfolio in Q2 2026, its #138 holding.
  • Ancora Advisors first reported a position in Emergent Biosolutions in Q3 2019 and has held it in 12 quarters since.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.